Form 4: Trulieve Cannabis Corp. Executive Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Joy Malivuk, Chief Accounting Officer of Trulieve Cannabis Corp., reports the acquisition of stock options and restricted stock units.
Summary
- On March 8, 2024, Joy Malivuk, the Chief Accounting Officer of Trulieve Cannabis Corp., was granted 17,500 restricted stock units (RSUs) and options to purchase 31,688 subordinate voting shares.
- The RSUs will vest in two installments: 50% on December 1, 2025, and the remaining 50% on December 1, 2026.
- The stock options have an exercise price of $10 and become exercisable in three annual installments starting December 1, 2024, and expiring March 8, 2031.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting the grant of stock options and RSUs. The impact is slightly positive as it incentivizes management.
Positives
- The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
- The vesting schedules for both RSUs and stock options encourage long-term commitment from the executive.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Equity compensation is a common practice in the cannabis industry to attract and retain talent, especially in a rapidly growing and evolving market.
Comparison to Industry Standards
- Comparing Trulieve's executive compensation structure to that of peers like Curaleaf, Green Thumb Industries, and Canopy Growth would provide a better understanding of whether the compensation is in line with industry standards.
- The vesting schedules are fairly standard, with multi-year vesting periods being common to incentivize long-term performance.
- The exercise price of $10 for the stock options would need to be compared to the current market price of Trulieve's stock to assess the potential value to the executive.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see the grants as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of transaction: grant of RSUs and stock options |
| 12/01/2024 | First vesting date for one-third of the stock options |
| 12/01/2025 | First vesting date for 50% of the RSUs and second vesting date for one-third of the stock options |
| 12/01/2026 | Second vesting date for the remaining 50% of the RSUs and third vesting date for one-third of the stock options |
| 03/08/2031 | Expiration date of the stock options |
| 03/12/2024 | Date of filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.